Drug therapy

Nonsteroidal anti-inflammatory drugs (NSAIDs) should be avoided after bariatric surgery because of the risk of gastric and marginal ulcer development. In many bariatric centers, proton pump inhibitor therapy is prescribed postoperatively, as evidence from cohort studies suggests that it may decrease ulcer risk. Endocrinologists and primary care providers should be prepared to adjust the dose of any medication that is dosed based on weight (e.g., levothyroxine), and to consider potential effects of malabsorption on a patient’s usual oral medications.In some cases, patients may need increased dosages of a drug to receive the same effect. In addition, some non-steroidal, anti-inflammatory drugs (Aspirin and NSAIDs) can cause ulcers or stomach irritation in patients who have undergone gastric bypass.

    Related Conference of Drug therapy

    November 29-30, 2018

    International Conference on Obesity and Diet Imbalance

    Bali, Indonesia
    January 31, February 01, 2019

    18th International Conference on Obesity, Diet and Nutrition

    Paris | France
    June 06-07, 2018

    International Congress on Obesity & Nutrition

    Philadelphuia, Pennsylvania USA
    March 15-16, 2019

    International Conference on Bariatric and Metabolic Surgery

    Novotel Brisbane, Brisbane, Australia
    March 25-26, 2019

    2nd World Obesity and Healthcare Congress

    Rotterdam, Netherlands
    June 21-22, 2019

    21st Global Obesity Meeting

    Novotel Brisbane, Australia

    Drug therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in